Mochi Health vs Red Mountain Weight Loss
Two GLP-1 desks, one scoreboard. We put Mochi Health and Red Mountain Weight Loss head-to-head on the published Brief Score — the same six factors, scored the same way.
Red Mountain Weight Loss
The verdict
Red Mountain Weight Loss takes this head-to-head.
Red Mountain Weight Loss scores 83 to 81 on our six-factor Brief Score — A long-established, LegitScript-certified weight-loss clinic with a competitive semaglutide line — but a steep $599 tirzepatide and a four-state footprint.
That doesn't make Mochi Health a bad call — it's best for readers in its served states who want a known consumer brand with a coaching bent. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Mochi Health | Red Mountain Weight Loss | |
|---|---|---|
| Brief Score | 81/100 (B−) | 83/100 (B) |
| Semaglutide | $138/mo | $149/mo |
| Tirzepatide | $238/mo | $599/mo |
| Coverage | 15 states | AZ, TX, OK, FL |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
Mochi Health: $138 sema / $238 tirz; footprint capped near 15 states.
Red Mountain Weight Loss: $149 sema but $599 tirz — one of the steepest tirz lines in the ranking; LegitScript-certified across four states.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.